This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta

Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta

While dapagliflozin-metformin dual fixed-dose combinations (FDCs) are increasingly used in type 2 diabetes (T2D) management, their complementary...
View All

Latest News and Guidelines

GLP-1 Receptor Agonists May Reduce CV and Thromboembolic Risks in Obesity and Autoimmune Disease: Study

GLP-1 Receptor Agonists May Reduce CV and Thromboembolic Risks in Obesity and Autoimmune Disease:...

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes: Study

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes:...

Noninvasive Glucose Monitor Shows Accuracy Comparable to Needle-Based CGMs: Study

Noninvasive Glucose Monitor Shows Accuracy Comparable to Needle-Based CGMs: Study

Researchers Discover Why Fructose Fails to Suppress Hunger Like Glucose

Researchers Discover Why Fructose Fails to Suppress Hunger Like Glucose

SGLT2 Inhibitors Emerge as Promising Disease-Modifying Therapy for Rheumatic Heart Disease: Review

SGLT2 Inhibitors Emerge as Promising Disease-Modifying Therapy for Rheumatic Heart Disease: Review

Abdominal Aortic Calcification on Lumbar X-rays Predicts Hip Fracture Risk: Study Reveals

Abdominal Aortic Calcification on Lumbar X-rays Predicts Hip Fracture Risk: Study Reveals

View All
X